Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cristina d'Abramo

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Journal of Personalized Medicine|September 11, 2020
Significance of Blood and Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: Sensitivity, Specificity and Potential for Clinical UseCristina d'Abramo, Luciano D'Adamio, Luca Giliberto
Journal of Neurochemistry|June 22, 2006
Troglitazone, a peroxisome proliferator-activated receptor-gamma agonist, decreases tau phosphorylation in CHOtau4R cellsCristina d'Abramo, Roberta Ricciarelli, Maria A Pronzato, et al.
Plos One|August 14, 2015
Passive Immunization in JNPL3 Transgenic Mice Using an Array of Phospho-Tau Specific AntibodiesCristina d'Abramo, Christopher M Acker, Heidy Jimenez, et al.
Plos One|May 3, 2013
Tau passive immunotherapy in mutant P301L mice: antibody affinity versus specificityCristina d'Abramo, Christopher M Acker, Heidy T Jimenez, et al.
Journal of Alzheimer'S Disease : JAD|September 15, 2012
Methods for measuring tau pathology in transgenic mouse modelsStefanie K Forest, Christopher M Acker, Cristina d'Abramo, et al.
Plos One|July 28, 2010
Transgenic expression of the amyloid-beta precursor protein-intracellular domain does not induce Alzheimer's Disease-like traits in vivoLuca Giliberto, Cristina d'Abramo, Christopher Michael Acker, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 21, 2010
Novel synthetic small-molecule activators of AMPK as enhancers of autophagy and amyloid-β peptide degradationValérie Vingtdeux, Pallavi Chandakkar, Haitian Zhao, et al.
Neurobiology of Aging|June 26, 2012
Sensitive quantitative assays for tau and phospho-tau in transgenic mouse modelsChristopher M Acker, Stefanie K Forest, Ray Zinkowski, et al.
Acta Neuropathologica Communications|August 24, 2018
Anti-tau conformational scFv MC1 antibody efficiently reduces pathological tau species in adult JNPL3 miceFrancesca Vitale, Luca Giliberto, Santiago Ruiz, et al.
IUBMB Life|September 17, 2004
Microarray analysis in Alzheimer's disease and normal agingRoberta Ricciarelli, Cristina d'Abramo, Sara Massone, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Journal of Personalized Medicine|September 11, 2020
Significance of Blood and Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: Sensitivity, Specificity and Potential for Clinical UseCristina d'Abramo, Luciano D'Adamio, Luca Giliberto
Journal of Neurochemistry|June 22, 2006
Troglitazone, a peroxisome proliferator-activated receptor-gamma agonist, decreases tau phosphorylation in CHOtau4R cellsCristina d'Abramo, Roberta Ricciarelli, Maria A Pronzato, et al.
Plos One|August 14, 2015
Passive Immunization in JNPL3 Transgenic Mice Using an Array of Phospho-Tau Specific AntibodiesCristina d'Abramo, Christopher M Acker, Heidy Jimenez, et al.
Plos One|May 3, 2013
Tau passive immunotherapy in mutant P301L mice: antibody affinity versus specificityCristina d'Abramo, Christopher M Acker, Heidy T Jimenez, et al.
Journal of Alzheimer'S Disease : JAD|September 15, 2012
Methods for measuring tau pathology in transgenic mouse modelsStefanie K Forest, Christopher M Acker, Cristina d'Abramo, et al.
Plos One|July 28, 2010
Transgenic expression of the amyloid-beta precursor protein-intracellular domain does not induce Alzheimer's Disease-like traits in vivoLuca Giliberto, Cristina d'Abramo, Christopher Michael Acker, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 21, 2010
Novel synthetic small-molecule activators of AMPK as enhancers of autophagy and amyloid-β peptide degradationValérie Vingtdeux, Pallavi Chandakkar, Haitian Zhao, et al.
Neurobiology of Aging|June 26, 2012
Sensitive quantitative assays for tau and phospho-tau in transgenic mouse modelsChristopher M Acker, Stefanie K Forest, Ray Zinkowski, et al.
Acta Neuropathologica Communications|August 24, 2018
Anti-tau conformational scFv MC1 antibody efficiently reduces pathological tau species in adult JNPL3 miceFrancesca Vitale, Luca Giliberto, Santiago Ruiz, et al.
IUBMB Life|September 17, 2004
Microarray analysis in Alzheimer's disease and normal agingRoberta Ricciarelli, Cristina d'Abramo, Sara Massone, et al.
Pageof 4